Grant: Discovery Grants Program - Individual
McGill University
$82,000.00
Transcriptional control of telomeric expression sites and antigenic variation
EF 2024-25
Résumé
Allelic exclusion of variant surface glycoprotein (VSG) genes is essential for the protozoa parasite Trypanosoma brucei spp. to evade the host immune response by antigenic variation. T. brucei expresses only one of its ~2,000 VSG genes at a time, which is exclusively transcribed at one of the 20 telomeric expression sites (ESs), and it periodically switches VSG gene expression to evade host antibody recognition. This VSG allelic exclusion mechanism ensures the expression of only one VSG protein on T. brucei surface, and the antigenic variation occurs by transcriptional switching between telomeric ESs or by VSG gene recombination. The molecular mechanisms that control VSG allelic exclusion and the periodic switching in VSG gene expression are poorly understood. My long-term goal is to understand the molecular basis underlying the control of antigenic variation with a focus on epigenetic and signalling mechanisms that control allelic exclusion, telomere silencing, and switching of VSG genes.
We previously found that the control of VSG allelic exclusion and switching involves a multiprotein complex and is regulated by a phosphoinositol system. This protein complex associates with telomeric ES chromatin and includes proteins that function in DNA binding, RNA processing, the nuclear lamina, and protein kinases and phosphatases. We will study the protein composition of this telomere regulatory complex and its functional role in VSG allelic exclusion. We will focus on the epigenetic role of phosphoinositides in the silencing activity of this protein complex, and the protein complex function in ES chromatin organization and VSG transcription. Specifically, we will (aim 1) use chemical cross-linking and mass spectrometry to map the telomere regulatory protein complex composition and determine how this composition changes during silencing and transcription of VSG genes. Moreover (aim 2), using CRISPR-Cas9 mutagenesis and biochemical assays we will determine how the phosphoinositol regulatory system controls the silencing of VSG genes. Finally (aim 3), we will determine how this protein complex affects the telomeric ES chromatin structural organization, and how the ES chromatin changes during silencing and transcription of VSG genes.
These studies will advance our understanding of the fundamental molecular processes that control allelic exclusion and antigenic variation in T. brucei and other organisms, e.g., Plasmodium spp., Giardia sp. It might also advance our knowledge of allelic exclusion of genes in other systems such as olfactory neuron receptors in mammals. My research program will also benefit economic and social sectors through the training of students in interdisciplinary, technological and innovative research.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2019-04658
Name nom
Cestari, Igor
Department département
Institute of Parasitology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2019
Award amount
82000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Transcriptional control of telomeric expression sites and antigenic variation
Keywords
allelic exclusion; trypanosomes; gene regulation; telomere silencing; antigenic variation; protein-protein interactions; chromatin organization; phosphoinositides; transcriptional control; immune evasion
Application summary
Allelic exclusion of variant surface glycoprotein (VSG) genes is essential for the protozoa parasite Trypanosoma brucei spp. to evade the host immune response by antigenic variation. T. brucei expresses only one of its ~2,000 VSG genes at a time, which is exclusively transcribed at one of the 20 telomeric expression sites (ESs), and it periodically switches VSG gene expression to evade host antibody recognition. This VSG allelic exclusion mechanism ensures the expression of only one VSG protein on T. brucei surface, and the antigenic variation occurs by transcriptional switching between telomeric ESs or by VSG gene recombination. The molecular mechanisms that control VSG allelic exclusion and the periodic switching in VSG gene expression are poorly understood. My long-term goal is to understand the molecular basis underlying the control of antigenic variation with a focus on epigenetic and signalling mechanisms that control allelic exclusion, telomere silencing, and switching of VSG genes.
We previously found that the control of VSG allelic exclusion and switching involves a multiprotein complex and is regulated by a phosphoinositol system. This protein complex associates with telomeric ES chromatin and includes proteins that function in DNA binding, RNA processing, the nuclear lamina, and protein kinases and phosphatases. We will study the protein composition of this telomere regulatory complex and its functional role in VSG allelic exclusion. We will focus on the epigenetic role of phosphoinositides in the silencing activity of this protein complex, and the protein complex function in ES chromatin organization and VSG transcription. Specifically, we will (aim 1) use chemical cross-linking and mass spectrometry to map the telomere regulatory protein complex composition and determine how this composition changes during silencing and transcription of VSG genes. Moreover (aim 2), using CRISPR-Cas9 mutagenesis and biochemical assays we will determine how the phosphoinositol regulatory system controls the silencing of VSG genes. Finally (aim 3), we will determine how this protein complex affects the telomeric ES chromatin structural organization, and how the ES chromatin changes during silencing and transcription of VSG genes.
These studies will advance our understanding of the fundamental molecular processes that control allelic exclusion and antigenic variation in T. brucei and other organisms, e.g., Plasmodium spp., Giardia sp. It might also advance our knowledge of allelic exclusion of genes in other systems such as olfactory neuron receptors in mammals. My research program will also benefit economic and social sectors through the training of students in interdisciplinary, technological and innovative research.